logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11058779 B1

PDFFull Text
Expired
Date of Patent:
Jul. 13, 2021

Filed:

Sep. 07, 2016

Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection

Applicant:

Sirnaomics, Inc., Gaithersburg, MD (US);

Inventors:

Patrick Y. Lu, Potomac, MD (US);

Vera Simonenko, Gaithersburg, MD (US);

Yibin Cai, Gaithersburg, MD (US);

John Xu, Germantown, MD (US);

David Evans, North Potomac, MD (US);

Assignee:

Sirnaomics, Inc., Gaithersburg, MD (US);

Attorney:

Edell, Shapiro & Finnan, LLC

Primary Examiner:

Terra C Gibbs

Int. Cl.
CPC ...
A61K 48/00 (2006.01); C12N 15/11 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01); A61K 9/51 (2006.01); A61K 9/127 (2006.01); A61K 47/54 (2017.01); A61P 31/14 (2006.01); A61K 47/28 (2006.01); C12N 15/113 (2010.01); C12N 15/88 (2006.01); B82Y 5/00 (2011.01);
U.S. Cl.
CPC ...
A61K 48/0066 (2013.01); A61K 9/127 (2013.01); A61K 9/5153 (2013.01); A61K 47/28 (2013.01); A61K 47/543 (2017.08); A61K 48/0008 (2013.01); A61P 31/14 (2018.01); C12N 15/1131 (2013.01); B82Y 5/00 (2013.01); C12N 15/88 (2013.01); C12N 2310/14 (2013.01); C12N 2320/31 (2013.01); C12N 2320/32 (2013.01);
Abstract

The present invention relates to compositions and methods for siRNA therapeutics for prevention and treatment of Middle East Respiratory Syndrome Corona Virus (MERS-CoV) infections. The compositions include a pharmaceutical composition comprising siRNA cocktails that target viral genes and pharmaceutically acceptable polymeric nanoparticle carriers and liposomal nanoparticle carriers.

Find Patent Forward Citations

Quick Actions:

Lu, Patrick. (2021). Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection (U.S. Patent No. 11058779). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11058779

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…